Aquaporin-4-dependent glymphatic solute transport in the rodent brain

  1. Humberto Mestre  Is a corresponding author
  2. Lauren M Hablitz
  3. Anna LB Xavier
  4. Weixi Feng
  5. Wenyan Zou
  6. Tinglin Pu
  7. Hiromu Monai
  8. Giridhar Murlidharan
  9. Ruth M Castellanos Rivera
  10. Matthew J Simon
  11. Martin M Pike
  12. Virginia Plá
  13. Ting Du
  14. Benjamin T Kress
  15. Xiaowen Wang
  16. Benjamin A Plog
  17. Alexander S Thrane
  18. Iben Lundgaard
  19. Yoichiro Abe
  20. Masato Yasui
  21. John H Thomas
  22. Ming Xiao  Is a corresponding author
  23. Hajime Hirase  Is a corresponding author
  24. Aravind Asokan  Is a corresponding author
  25. Jeffrey J Iliff  Is a corresponding author
  26. Maiken Nedergaard  Is a corresponding author
  1. University of Rochester Medical Center, United States
  2. University of Copenhagen, Denmark
  3. Nanjing Medical University, China
  4. RIKEN, Japan
  5. The University of North Carolina at Chapel Hill, United States
  6. Oregon Health and Science University, United States
  7. Haukeland University Hospital, Norway
  8. Lund University, Sweden
  9. Keio University, Japan
  10. University of Rochester, United States

Abstract

The glymphatic system is a brain-wide clearance pathway; its impairment contributes to the accumulation of amyloid-β. Influx of cerebrospinal fluid(CSF) depends upon the expression and perivascular localization of the astroglial water channel aquaporin-4(AQP4). Prompted by a recent failure to find an effect of Aqp4 knock-out(KO) on CSF and interstitial fluid(ISF) tracer transport, five groups re-examined the importance of AQP4 in glymphatic transport. We concur that CSF influx is higher in wildtype mice than in four different Aqp4 KO lines and in one line that lacks perivascular AQP4(Snta1 KO). Meta-analysis of all studies demonstrated a significant decrease in tracer transport in KO mice and rats compared to controls. Meta-regression indicated that anesthesia, age, and tracer delivery explain the opposing results. We also report that intrastriatal injections suppress glymphatic function. This validates the role of AQP4 in accordance with the glymphatic system and shows that invasive procedures should not be utilized.

Data availability

All data generated or analysed during this study are included in the manuscript.

Article and author information

Author details

  1. Humberto Mestre

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    For correspondence
    humberto_mestre@urmc.rochester.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5876-5397
  2. Lauren M Hablitz

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Anna LB Xavier

    Center for Translational Neuromedicine, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  4. Weixi Feng

    Jiangsu Province Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Wenyan Zou

    Jiangsu Province Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Tinglin Pu

    Jiangsu Province Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Hiromu Monai

    Center for Brain Science, RIKEN, Wako, Japan
    Competing interests
    The authors declare that no competing interests exist.
  8. Giridhar Murlidharan

    Gene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ruth M Castellanos Rivera

    Gene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Matthew J Simon

    Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Martin M Pike

    Advanced Imaging Research Center, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Virginia Plá

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Ting Du

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Benjamin T Kress

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Xiaowen Wang

    Center for Brain Science, RIKEN, Wako, Japan
    Competing interests
    The authors declare that no competing interests exist.
  16. Benjamin A Plog

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Alexander S Thrane

    Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway
    Competing interests
    The authors declare that no competing interests exist.
  18. Iben Lundgaard

    Department of Experimental Medical Science, Lund University, Lund, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  19. Yoichiro Abe

    Department of Pharmacology, Keio University, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6163-8794
  20. Masato Yasui

    Department of Pharmacology, Keio University, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.
  21. John H Thomas

    Department of Mechanical Engineering, University of Rochester, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Ming Xiao

    Jiangsu Province Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China
    For correspondence
    mingx@njmu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
  23. Hajime Hirase

    Center for Brain Science, RIKEN, Wako, Japan
    For correspondence
    hajime.hirase@riken.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3806-6905
  24. Aravind Asokan

    Gene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, United States
    For correspondence
    aravind_asokan@med.unc.edu
    Competing interests
    The authors declare that no competing interests exist.
  25. Jeffrey J Iliff

    Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, United States
    For correspondence
    iliffj@ohsu.edu
    Competing interests
    The authors declare that no competing interests exist.
  26. Maiken Nedergaard

    Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, United States
    For correspondence
    maiken_nedergaard@urmc.rochester.edu
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institutes of Health (NS100366)

  • Maiken Nedergaard

Japan Society for the Promotion of Science (18H02606)

  • Masato Yasui

Human Frontier Science Program (RGP0036/2014)

  • Hajime Hirase

Japan Society for the Promotion of Science (Core-to-Core Program)

  • Hajime Hirase

Lundbeckfonden (Visiting Professorship)

  • Hajime Hirase

Knut och Alice Wallenbergs Stiftelse (Helse Vet)

  • Alexander S Thrane

National Institutes of Health (NS061800)

  • Aravind Asokan

National Institutes of Health (AG048769)

  • Maiken Nedergaard

National Institutes of Health (AG054456)

  • Jeffrey J Iliff

National Institutes of Health (NS099371)

  • Aravind Asokan

National Institutes of Health (HL089221)

  • Aravind Asokan

National Institutes of Health (NS089709)

  • Jeffrey J Iliff

National Institutes of Health (NS078394)

  • Maiken Nedergaard

National Institutes of Health (AG048769)

  • Maiken Nedergaard

Japan Society for the Promotion of Science (18K14859)

  • Hiromu Monai

Japan Society for the Promotion of Science (16H01888)

  • Hajime Hirase

Japan Society for the Promotion of Science (18H05150)

  • Hajime Hirase

Japan Society for the Promotion of Science (17K19637)

  • Yoichiro Abe

Japan Society for the Promotion of Science (16H05134)

  • Yoichiro Abe

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. David Kleinfeld, University of California, San Diego, United States

Ethics

Animal experimentation: All experiments were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (IACUC-1601106), Wako Animal Experiment Committee, RIKEN (Recombinant DNA experimentation protocol: 2016-038; Animal experimentation protocol: H29-2-227), The University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee (protocol 15-109), the University Committee on Animal Resources of the University of Rochester (protocol 2011-023), and the IACUC of Oregon Health and Science University (protocol IP00000394). All experiments were performed in accordance with the approved guidelines and regulations. All efforts were made to minimize animal suffering and to reduce the number of animals used for the experiments.

Version history

  1. Received: July 20, 2018
  2. Accepted: December 17, 2018
  3. Accepted Manuscript published: December 18, 2018 (version 1)
  4. Accepted Manuscript updated: December 19, 2018 (version 2)
  5. Version of Record published: December 27, 2018 (version 3)
  6. Version of Record updated: December 28, 2018 (version 4)

Copyright

© 2018, Mestre et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,365
    views
  • 1,913
    downloads
  • 363
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Humberto Mestre
  2. Lauren M Hablitz
  3. Anna LB Xavier
  4. Weixi Feng
  5. Wenyan Zou
  6. Tinglin Pu
  7. Hiromu Monai
  8. Giridhar Murlidharan
  9. Ruth M Castellanos Rivera
  10. Matthew J Simon
  11. Martin M Pike
  12. Virginia Plá
  13. Ting Du
  14. Benjamin T Kress
  15. Xiaowen Wang
  16. Benjamin A Plog
  17. Alexander S Thrane
  18. Iben Lundgaard
  19. Yoichiro Abe
  20. Masato Yasui
  21. John H Thomas
  22. Ming Xiao
  23. Hajime Hirase
  24. Aravind Asokan
  25. Jeffrey J Iliff
  26. Maiken Nedergaard
(2018)
Aquaporin-4-dependent glymphatic solute transport in the rodent brain
eLife 7:e40070.
https://doi.org/10.7554/eLife.40070

Share this article

https://doi.org/10.7554/eLife.40070

Further reading

    1. Cell Biology
    2. Neuroscience
    Mariana I Tsap, Andriy S Yatsenko ... Halyna R Shcherbata
    Research Article Updated

    Mutations in Drosophila Swiss cheese (SWS) gene or its vertebrate orthologue neuropathy target esterase (NTE) lead to progressive neuronal degeneration in flies and humans. Despite its enzymatic function as a phospholipase is well established, the molecular mechanism responsible for maintaining nervous system integrity remains unclear. In this study, we found that NTE/SWS is present in surface glia that forms the blood-brain barrier (BBB) and that NTE/SWS is important to maintain its structure and permeability. Importantly, BBB glia-specific expression of Drosophila NTE/SWS or human NTE in the sws mutant background fully rescues surface glial organization and partially restores BBB integrity, suggesting a conserved function of NTE/SWS. Interestingly, sws mutant glia showed abnormal organization of plasma membrane domains and tight junction rafts accompanied by the accumulation of lipid droplets, lysosomes, and multilamellar bodies. Since the observed cellular phenotypes closely resemble the characteristics described in a group of metabolic disorders known as lysosomal storage diseases (LSDs), our data established a novel connection between NTE/SWS and these conditions. We found that mutants with defective BBB exhibit elevated levels of fatty acids, which are precursors of eicosanoids and are involved in the inflammatory response. Also, as a consequence of a permeable BBB, several innate immunity factors are upregulated in an age-dependent manner, while BBB glia-specific expression of NTE/SWS normalizes inflammatory response. Treatment with anti-inflammatory agents prevents the abnormal architecture of the BBB, suggesting that inflammation contributes to the maintenance of a healthy brain barrier. Considering the link between a malfunctioning BBB and various neurodegenerative diseases, gaining a deeper understanding of the molecular mechanisms causing inflammation due to a defective BBB could help to promote the use of anti-inflammatory therapies for age-related neurodegeneration.

    1. Neuroscience
    Mohsen Sadeghi, Reza Sharif Razavian ... Dagmar Sternad
    Research Article

    Natural behaviors have redundancy, which implies that humans and animals can achieve their goals with different strategies. Given only observations of behavior, is it possible to infer the control objective that the subject is employing? This challenge is particularly acute in animal behavior because we cannot ask or instruct the subject to use a particular strategy. This study presents a three-pronged approach to infer an animal’s control objective from behavior. First, both humans and monkeys performed a virtual balancing task for which different control strategies could be utilized. Under matched experimental conditions, corresponding behaviors were observed in humans and monkeys. Second, a generative model was developed that represented two main control objectives to achieve the task goal. Model simulations were used to identify aspects of behavior that could distinguish which control objective was being used. Third, these behavioral signatures allowed us to infer the control objective used by human subjects who had been instructed to use one control objective or the other. Based on this validation, we could then infer objectives from animal subjects. Being able to positively identify a subject’s control objective from observed behavior can provide a powerful tool to neurophysiologists as they seek the neural mechanisms of sensorimotor coordination.